Aptevo Therapeutics Inc (APVO)
5.14
+0.30
(+6.20%)
USD |
NASDAQ |
Dec 26, 16:00
5.18
+0.04
(+0.78%)
After-Hours: 20:00
Aptevo Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Trevi Therapeutics Inc | 7.667M |
| Keros Therapeutics Inc | -0.386M |
| Johnson & Johnson | -3.128B |
| Eyenovia Inc | -0.0016M |
| Applied Therapeutics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.222M |
| Cash from Financing (Quarterly) | 4.909M |
| Free Cash Flow | -23.28M |
| Free Cash Flow Per Share (Quarterly) | -18.32 |
| Free Cash Flow Yield | -5.70K% |